Paradigm Biopharmaceuticals Ltd at NWR Healthcare Conference (Virtual) Transcript
Hello, and welcome back to the NWR Virtual Healthcare Conference. My name is Matt Wright. Next up, we have Paradigm Biopharmaceuticals, which is listed on the ASX under the ticker PAR. And joining us on behalf of Paradigm today is CEO Paul Rennie.
(Conference Instructions) I'll now pass it over to Paul to give the presentation. Please go ahead.
Thank you very much, Matt, and thank you, everyone, for attending. I'm very pleased to be here and present the Paradigm story. I'm just back from a major international conference on osteoarthritis, called OARSI, where many big pharma companies presented their data in relation to research that's going on within the field of osteoarthritis. And I was very, very privileged to say that Paradigm got invited to talk at the clinical trials symposia, where other pharma companies, along with Paradigm, spoke about their clinical development progress thus far.
And one of the amazing things
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |